Description：The peptide is used to block Anti-CD85e Antibody (#CPA5505) reactivity.Form：Lyophilized powderGene Symbol：LILRA2; LILRA3Alternative Names：LILRA2; ILT1; LIR7; Leukocyte immunoglobulin-like receptor subfamily A member 2; CD85 antigen-like family member H; Immunoglobulin-like transcript 1; ILT-1; Leukocyte immunoglobulin-like receptor 7; LIR-7; CD85h; LILRA3; ILT6; LIR4; Leukocyte immunoglobulin-like receptor subfamily A member 3; CD85 antigen-like family member E; Immunoglobulin-like transcript 6; ILT-6; Leukocyte immunoglobulin-like receptor 4; LIR-4; Monocyte inhibitory receptor HM43/HM31; CD85e Entrez Gene (Human)： 11027; 11026; SwissProt (Human)： Q8N149; Q8N6C8; Purity：>85%Directions for Use：Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control：The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability：Shipped at 4°C. Store at -20°C for one year.